Fenner MH - Search Results

1

Targeted therapies for patients with germ cell tumors.

Fenner MH, Beutel G, Grünwald V. Fenner MH, et al. Expert Opin Investig Drugs. 2008 Apr;17(4):511-22. doi: 10.1517/13543784.17.4.511. Expert Opin Investig Drugs. 2008. PMID: 18363516 Review.

2

Retrospective analyses of patient characteristics having predictive impact on survival under everolimus.

Seidel C, Fenner M, Reuter C, Merseburger AS, Ganser A, Grünwald V. Seidel C, et al. Onkologie. 2011;34(3):111-4. doi: 10.1159/000324668. Epub 2011 Feb 15. Onkologie. 2011. PMID: 21358215

3

Efficacy of sunitinib re-exposure after failure of an mTOR inhibitor in patients with metastatic RCC.

Grünwald V, Weikert S, Seidel C, Busch J, Johannsen A, Fenner M, Reuter C, Ganser A, Johannsen M. Grünwald V, et al. Onkologie. 2011;34(6):310-4. doi: 10.1159/000328575. Epub 2011 May 6. Onkologie. 2011. PMID: 21625184

4

Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma.

Seidel C, Busch J, Weikert S, Steffens S, Fenner M, Ganser A, Grünwald V. Seidel C, et al. Eur J Cancer. 2012 May;48(7):1023-30. doi: 10.1016/j.ejca.2012.02.048. Epub 2012 Mar 20. Eur J Cancer. 2012. PMID: 22436979

5

Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST).

Seidel C, Fenner M, Länger F, Bantel H, Ganser A, Grünwald V. Seidel C, et al. BMC Cancer. 2012 May 21;12:186. doi: 10.1186/1471-2407-12-186. BMC Cancer. 2012. PMID: 22612794 Free PMC article.

6

Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patients.

Seidel C, Fenner M, Merseburger AS, Reuter C, Ivanyi P, Länger F, Ganser A, Grünwald V. Seidel C, et al. World J Urol. 2011 Jun;29(3):355-60. doi: 10.1007/s00345-010-0642-3. Epub 2011 Jan 22. World J Urol. 2011. PMID: 21258806

7

Treatment of everolimus-resistant metastatic renal cell carcinoma with VEGF-targeted therapies.

Grünwald V, Seidel C, Fenner M, Ganser A, Busch J, Weikert S. Grünwald V, et al. Br J Cancer. 2011 Nov 22;105(11):1635-9. doi: 10.1038/bjc.2011.389. Epub 2011 Oct 27. Br J Cancer. 2011. PMID: 22033275 Free PMC article. Clinical Trial.

8

Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer.

Reuter CW, Morgan MA, Ivanyi P, Fenner M, Ganser A, Grünwald V. Reuter CW, et al. World J Urol. 2010 Jun;28(3):391-8. doi: 10.1007/s00345-010-0527-5. Epub 2010 Mar 14. World J Urol. 2010. PMID: 20229232

9

Peroxisome proliferator-activated receptor-gamma ligands for the treatment of breast cancer.

Fenner MH, Elstner E. Fenner MH, et al. Expert Opin Investig Drugs. 2005 Jun;14(6):557-68. doi: 10.1517/13543784.14.6.557. Expert Opin Investig Drugs. 2005. PMID: 16004588 Review.

10

Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study.

Oechsle K, Honecker F, Cheng T, Mayer F, Czaykowski P, Winquist E, Wood L, Fenner M, Glaesener S, Hartmann JT, Chi K, Bokemeyer C, Kollmannsberger C. Oechsle K, et al. Ann Oncol. 2011 Dec;22(12):2654-2660. doi: 10.1093/annonc/mdr026. Epub 2011 Mar 17. Ann Oncol. 2011. PMID: 21415240 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page